Explore our primary high-throughput sequencing and analysis services tailored for academic and industrial research.
For decades, the field of genomics has wrestled with the limitations of draft genome assemblies. Traditional sequencing approaches, heavily reliant on short-read technologies, left significant gaps in repetitive regions, centromeres, telomeres, and segmental duplications. These unresolved regions—often referred to as the "dark matter" of the genome—contain critical regulatory elements, structural variants, and evolutionary information. The transition to Telomere-to-Telomere (T2T) gap-free chromosome assembly represents one of the most significant technological leaps in modern biology, establishing a new standard for genomics completeness.
A Milestone in Genomic Science: T2T assemblies resolve every single base pair from one end of a chromosome to the other, unlocking biological insights that were previously inaccessible to researchers worldwide.
Achieving a gap-free T2T genome requires the synergy of long-read sequencing technologies and sophisticated bioinformatics pipelines. Pacific Biosciences (PacBio) High-Fidelity (HiFi) reads provide exceptional single-molecule accuracy (>99.9%) at lengths of 10-25 kb, which is ideal for resolving complex heterozygous regions. Simultaneously, Oxford Nanopore Technologies (ONT) ultra-long reads, which can span hundreds of kilobases, provide the structural scaffold necessary to bridge massive centromeric repeats and telomeric arrays. By combining these complementary modalities with Hi-C chromosomal conformation capture, BMKGene delivers complete, haplotype-resolved, gap-free assemblies that serve as absolute reference maps for comparative genomics and functional studies.
The commercial demand for T2T gap-free assemblies has expanded rapidly from niche academic projects to mainstream industrial research. In agricultural biotechnology, crop breeders are leveraging T2T genomes to identify structural variations (SVs) and copy number variations (CNVs) associated with complex traits such as drought tolerance, disease resistance, and yield optimization. Traditional draft genomes often fail to capture these large-scale variations because repetitive transposable elements—where many structural changes occur—are collapsed or omitted during assembly.
In the biopharmaceutical and clinical sectors, T2T chromosome assembly is paving the way for advanced gene therapies and precision medicine. Resolving highly homologous gene clusters, such as the human leukocyte antigen (HLA) complex and immunoglobulin loci, is critical for understanding immune responses and designing targeted therapeutics. As sequencing costs continue to decline, industries are moving away from standard draft references, adopting T2T assemblies as the baseline requirement for intellectual property filings, synthetic biology designs, and regulatory approvals of genetically engineered systems.
Many of the world's most critical crops, such as wheat, sugarcane, and cotton, possess complex polyploid genomes with high levels of heterozygosity and duplication. Standard sequencing methods lead to chimeric assemblies where homeologous chromosomes are falsely merged. Haplotype-resolved T2T assembly allows academic teams to isolate maternal and paternal alleles, mapping regulatory networks and promoter regions with single-nucleotide resolution. This accelerates marker-assisted selection and CRISPR-based gene editing strategies.
Comparative genomics relies on precise synteny mapping to trace evolutionary events. By eliminating assembly gaps, researchers can accurately identify chromosomal fusion, fission, inversions, and translocations across closely related species. These structural rearrangements are key drivers of speciation and phenotypic diversity, and having a gap-free reference is vital for reconstructing ancestral genomes.
Human disease research benefits immensely from T2T assemblies. Centromeres, which are crucial for cell division, are hotspots for chromosomal instability in cancer. T2T sequencing allows researchers to explore satellite DNA dynamics, epigenetic modifications (such as methylation profiling directly from long-read data), and structural variations in centromeric regions, offering new avenues for cancer therapeutics and genetic disease diagnosis.
Biomarker Technologies (BMKGene) is deeply committed to collaborative science. We understand that academic research requires not only high-quality data but also collaborative expertise in bioinformatics and experimental design. Our Academic Cooperation Program is designed to support universities and research institutes globally through joint grant applications, flexible co-authorship opportunities, and customized bioinformatics workflows.
By partnering with BMKGene, academic laboratories gain access to our massive computing infrastructure and cutting-edge sequencing platforms. We assign dedicated project managers and PhD-level bioinformatics specialists to guide projects from DNA extraction protocols (especially critical for high-molecular-weight DNA required for ultra-long sequencing) to manuscript-ready figures and database submissions.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.
Our commitment to quality, research integrity, and technical innovation is reflected in our extensive portfolio of international certifications, patents, and software copyrights.
Select from our comprehensive list of sequencing and genomic analysis products designed to accelerate your scientific discoveries.